Atlas Trials

A Study to Assess AMG 701 Montherapy, or in Combination With Pomalidomide, With or Without, Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Clinical trial NCT03287908 · TERMINATED

Trial details

NCT number
NCT03287908
Sponsor
Amgen
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed/Refractory Multiple Myeloma
Start date
2017-11-13
Primary completion
2023-06-30
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.